Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid fillers.
hyaluronic acid filler
ultrasound
vascular adverse event
Journal
Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
received:
06
05
2019
revised:
05
07
2019
accepted:
11
07
2019
pubmed:
22
7
2019
medline:
21
12
2022
entrez:
21
7
2019
Statut:
ppublish
Résumé
Hyaluronic acid fillers are known for a reliable safety profile, but complications do occur, even serious vascular adverse events. To improve the treatment outcome after a vascular adverse event with use of hyaluronic acid filler treatments. Duplex ultrasonography is used to detect the hyaluronic acid filler causing the intra-arterial obstruction. If treated in time, 1 single treatment of ultrasonographically guided injections of hyaluronidase into the filler deposit will prevent skin necrosis. Because the use of duplex ultrasonography adds extra essential information, its use may become an integral part of the prevention and treatment of injection adverse events.
Sections du résumé
BACKGROUND
Hyaluronic acid fillers are known for a reliable safety profile, but complications do occur, even serious vascular adverse events.
OBJECTIVE
To improve the treatment outcome after a vascular adverse event with use of hyaluronic acid filler treatments.
METHODS
Duplex ultrasonography is used to detect the hyaluronic acid filler causing the intra-arterial obstruction.
RESULTS
If treated in time, 1 single treatment of ultrasonographically guided injections of hyaluronidase into the filler deposit will prevent skin necrosis.
CONCLUSION
Because the use of duplex ultrasonography adds extra essential information, its use may become an integral part of the prevention and treatment of injection adverse events.
Identifiants
pubmed: 31325548
pii: S0190-9622(19)32392-8
doi: 10.1016/j.jaad.2019.07.032
pii:
doi:
Substances chimiques
Dermal Fillers
0
Hyaluronic Acid
9004-61-9
Hyaluronoglucosaminidase
EC 3.2.1.35
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
79-85Informations de copyright
Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.